Don't Just Read the News, Understand It.

Browser Extension

Thursday, May 29, 2025

US Edition

Subscribe Login

Israel-Hamas Conflict

Artificial Intelligence

Republican Party

Democratic Party

Healio image

News from Healio

Topics Most Covered by Healio

Sources Covering Similar Topics

Suggest a source

Looking for a source we don't already have? Suggest one here.

News Home Page Local News Blindspot Feed International Covid-19

International North America South America Europe Asia Australia Africa

Trending Internationally Memorial Day Social Media Artificial Intelligence Donald Trump Republican Party

Trending in U.S.Israel-Hamas Conflict Memorial Day Republican Party US Politics Democratic Party

Trending in U.K.Israel-Hamas Conflict UK Economy Premier League Manchester United Soccer

Trending Topics

Memorial Day Social Media Artificial Intelligence Donald Trump Israel-Hamas Conflict

CompanyAbout History Mission Blog Testimonials Group Subscriptions Subscribe Gift Free Trial Careers Affiliates

HelpHelp Center FAQ Contact Us For Educators/Libraries Media Bias Ratings Ownership and Factuality Ratings Referral Code News Sources Topics

ToolsApp Browser Extension Daily Newsletter Blindspot Report Newsletter Burst Your Bubble Newsletter Timelines

Gift Privacy Policy Manage Cookies Terms and Conditions

© 2025 Snapwise Inc

Search Blindspot Local

News from Healio

Stay current with all the latest and breaking news from Healio. Compare headlines and media bias behind news outlets on stories breaking today.

We’ve aggregated 5 of Healio’s headlines and news stories over the past 3 months.

Healio’s media bias is Center. Ground News assigned this score by aggregating media bias ratings of a Center rating from Ad Fontes Media .

Healio’s factuality rating is Very High. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Stay current with all the latest and breaking news from Healio. Compare headlines and media bias behind news outlets on stories breaking today. We’ve aggregated 5 of Healio’s headlines and news stories over the past 3 months.

Healio’s media bias is Center. Ground News assigned this score by aggregating media bias ratings of a Center rating from Ad Fontes Media . Healio’s factuality rating is Very High. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Healio

Where is Healio located?Healio's Website

Media Bias Ratings

Average Bias Rating:

Center

Center

byAd Fontes Media

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Healio News

New FDA restrictions will make COVID-19 vaccines only available to elderly and people with medical conditions

Vaccines · United States

New FDA restrictions will make COVID-19 vaccines only available to elderly and people with medical conditions

65% Center coverage: 331 sources

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65, effectively limiting their availability this fall to older adults and those with a higher risk of developing severe illness, FDA leaders said on Tuesday.See the Story

FDA warns of ‘rare but severe itching’ after using popular allergy medications

FDA · United States

FDA warns of ‘rare but severe itching’ after using popular allergy medications

83% Center coverage: 31 sources

Hundreds of people who stopped using allergy medications like Zyrtec and Xyzal noticed an uncomfortable new side effect, the U.S. Food and Drug Administration said in a warning issued this month. In “rare but severe” cases, and for unknown reasons, some who quit using the drugs became very itchy and had to seek medical help.See the Story

FDA Committee Recommends Formula for Fall COVID-19 Vaccines

Vaccines · United States

FDA Committee Recommends Formula for Fall COVID-19 Vaccines

75% Center coverage: 4 sources

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the first time, will be limited to certain groups — target the JN.1 lineage of SARS-CoV-2.See the Story

Breaking News Topics Related to Healio

Vaccines

Health

FDA

United States

Science

Coronavirus

Similar News Topics

KATC

The Daily Signal

thepublicsradio.org

BizToc

WRTV

MAHA Report Identifies Possible Chronic Disease Drivers in Kids, but Experts Raise Concern

MAHA Report Identifies Possible Chronic Disease Drivers in Kids, but Experts Raise Concern

75% Right coverage: 4 sources

On Thursday, the “Make America Healthy Again” commission released its first report on the potential contributors of chronic diseases, such as diabetes, mental illness and obesity, among American youth.The commission, headed by HHS Secretary Robert F. Kennedy Jr., said it identified four potential causes:MAHA · United States See the Story

AF, Atrial Flutter in COVID-19 May Be Tied to Inflammation

AF, Atrial Flutter in COVID-19 May Be Tied to Inflammation

100% Center coverage: 1 sources

New-onset atrial fibrillation and atrial flutter are as common in hospitalized patients with influenza as with COVID-19, suggesting the connection between the arrhythmias and COVID-19 is related to the general inflammatory state.Although COVID-19 was known to increase inflammatory markers associated with atrial arrhythmias, the relationship of the inflammation to COVID-19 was not known, so theInfluenza See the Story

Dosing Underway in Phase 2a Trial of PP405 for Androgenetic Alopecia

Dosing Underway in Phase 2a Trial of PP405 for Androgenetic Alopecia

100% Center coverage: 1 sources

The first patients have been dosed in a phase 2a clinical trial of PP405 for the treatment of androgenetic alopecia, Pelage Pharmaceuticals announced in a press release. The randomized, placebo-controlled trial will evaluate the safety and efficacy of PP405 in 60 men and women with the condition, also known as pattern baldness.See the Story

2-in-1 COVID-flu vaccine looks promising, but approval could be delayed

2-in-1 COVID-flu vaccine looks promising, but approval could be delayed

100% Center coverage: 2 sources

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval may be delayed.Influenza See the Story

In what ways can mental health professionals help in the care of orthopedic patients?

In what ways can mental health professionals help in the care of orthopedic patients?

100% Center coverage: 1 sources

When we are looking at the role of a mental health professional, we are bridging this gap between physical healing and emotional resilience. There is so much with pain in the limbic system that people do not always know about, and that is where a counselor can come in and do some work to support the patient. The limbic system is involved in processing emotional memory, motivation and stressMental Health Read Article

How to Find Safe Eye Drops Now That 75,000 Cases Were Just Recalled

How to Find Safe Eye Drops Now That 75,000 Cases Were Just Recalled

78% Center coverage: 55 sources

If you currently have eye drops in your medicine cabinet, make sure they're not part of a recent recall. Plus, how to buy safe eye drops.Pharma · United States See the Story

Drug Used by Trump Has Suicide Risk; FDA's 'Aggressive' AI Rollout; 1K Measles Cases

Drug Used by Trump Has Suicide Risk; FDA's 'Aggressive' AI Rollout; 1K Measles Cases

50% Center coverage: 4 sources

(MedPage Today) -- Note that some links may require registration or subscription. Thoughts of suicide was confirmed as a side effect of finasteride (Propecia, Proscar), the European Medicines Agency (EMA) said. The popular drug -- previously...Donald Trump See the Story

Combination immunotherapy better than single agent in head, neck cancer

Combination immunotherapy better than single agent in head, neck cancer

100% Center coverage: 2 sources

Neoadjuvant combination immunotherapy may improve survival compared with single-agent therapy for patients with head and neck squamous cell carcinoma, according to results of a randomized phase 2 trial.Two different doublets — nivolumab (Opdivo, Bristol Myers Squibb) plus relatlimab (Opdualag, Bristol Myers Squibb), as well as nivolumab plus ipilimumab (Yervoy, Bristol Myers Squibb) —Detroit, Michigan · Detroit See the Story